Structure-Function Analysis of Sarcospan
Sarcospan 的结构功能分析
基本信息
- 批准号:8213714
- 负责人:
- 金额:$ 31.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-24 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdhesionsAffectAgrinBerylliumBindingBiochemicalCharacteristicsCommunicationComplexCytoskeletonDataDiseaseDuchenne muscular dystrophyDystroglycanDystrophinElementsExhibitsExtracellular MatrixFundingGenesGlycoproteinsGrantHealthIntegral Membrane ProteinIntegrinsInternetKnockout MiceLaboratoriesLamininLinkMasksMechanicsMediatingMembraneMolecularMusMuscleMuscle ContractionMuscular DystrophiesMutationPathologyPeripheralPhenotypePhysiologicalPlayPositioning AttributePreventionPropertyProteinsResearchRoleSarcoglycansSarcolemmaSignal TransductionSkeletal MuscleStructureSynapsesTestingTherapeuticTransferaseTransgenic MiceTransgenic OrganismsUtrophinageddesignhuman PHEMX proteinhuman SSPN proteinimprovedinterestmdx mousemuscle strengthoverexpressionprematureprotein complexscaffold
项目摘要
DESCRIPTION (provided by applicant): In skeletal muscle, the dystrophin-glycoprotein complex is located at the sarcolemma and is composed of peripheral and integral membrane proteins. As a whole, this complex links the extracellular matrix to the intracellular actin cytoskeleton and provides structural stability to the sarcolemma during muscle contraction. Duchenne muscular dystrophy, the most common form of dystrophy, is caused by mutations in the dystrophin gene that result in loss of dystrophin protein and the entire dystrophin-glycoprotein complex. My research group has pioneered several key discoveries related to the function of sarcospan, an integral component of the dystrophin-glycoprotein complex. We have shown that sarcospan plays an important role in mediating protein interactions within this complex. Sarcospan affects communication between the dystrophin-glycoprotein complex and the extracellular matrix. Importantly, we demonstrate that mild sarcospan over-expression in mdx mice, which possess a mutation in the murine dystrophin gene, rescues muscular dystrophy by stabilizing expression of a complex of proteins that is functionally analogous to the dystrophin-glycoprotein complex. We propose to investigate the molecular mechanism(s) of SSPN-mediated amelioration of mdx phenotype and reveal the compensatory mechanisms that may mask a potentially interesting and enlightening phenotype in the SSPN-null mice. We will also complete our characterization of SSPN's `rescue effect' by examining muscle mechanics. Our hypothesis provides a mechanism for cross-talk between transmembrane/cytoskeletal complexes (i.e. integrins and DGC) that may illuminate how compensatory mechanisms are regulated. Results from each of the Aims will provide new information on the role of sarcospan as an important structural element within the dystrophin-glycoprotein complex and uncover new information on sarcospan's function in signaling and disease. PUBLIC HEALTH RELEVANCE Our proposal addresses questions related to how disruption of the dystrophin-glycoprotein complex causes Duchenne muscular dystrophy. During our previous funding period, we discovered that sarcospan, an integral component of the dystrophin-glycoprotein complex, is able to ameliorate dystrophin-deficient muscular dystrophy in mice. We plan to test the physiological properties of these mice and investigate the mechanisms of sarcospan amelioration.
描述(由申请人提供):在骨骼肌中,肌营养不良蛋白-糖蛋白复合物位于肌膜处,由外周膜蛋白和内在膜蛋白组成。总体而言,该复合物将细胞外基质与细胞内肌动蛋白细胞骨架连接起来,并在肌肉收缩期间为肌膜提供结构稳定性。杜氏肌营养不良症是最常见的营养不良形式,是由肌营养不良蛋白基因突变引起的,导致肌营养不良蛋白和整个肌营养不良蛋白-糖蛋白复合物的丢失。我的研究小组开创了与肌跨功能相关的几项关键发现,肌跨是肌营养不良蛋白-糖蛋白复合物的一个组成部分。我们已经证明肌跨在介导该复合物内的蛋白质相互作用中发挥着重要作用。 Sarcospan 影响肌营养不良蛋白-糖蛋白复合物与细胞外基质之间的通讯。重要的是,我们证明,在具有鼠抗肌营养不良蛋白基因突变的 mdx 小鼠中,肌跨膜轻度过度表达,可以通过稳定功能类似于抗肌营养不良蛋白-糖蛋白复合物的蛋白质复合物的表达来挽救肌营养不良症。我们建议研究 SSPN 介导的 mdx 表型改善的分子机制,并揭示可能掩盖 SSPN 缺失小鼠中潜在有趣和启发性表型的补偿机制。我们还将通过检查肌肉力学来完成对 SSPN“救援效应”的表征。我们的假设提供了跨膜/细胞骨架复合物(即整联蛋白和 DGC)之间的串扰机制,这可能阐明补偿机制是如何调节的。每个目标的结果都将提供关于肌跨作为肌营养不良蛋白-糖蛋白复合物中重要结构元件的作用的新信息,并揭示关于肌跨在信号传导和疾病中的功能的新信息。公共卫生相关性 我们的提案解决了与肌营养不良蛋白-糖蛋白复合物破坏如何导致杜氏肌营养不良相关的问题。在我们之前的资助期间,我们发现肌跨蛋白(肌营养不良蛋白-糖蛋白复合物的组成部分)能够改善小鼠肌营养不良蛋白缺陷型肌营养不良症。我们计划测试这些小鼠的生理特性并研究肌跨改善机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachelle Hope Crosbie其他文献
Rachelle Hope Crosbie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachelle Hope Crosbie', 18)}}的其他基金
Muscle Cell Biology, Pathophysiology, and Therapeutics
肌肉细胞生物学、病理生理学和治疗学
- 批准号:
10205391 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Muscle Cell Biology, Pathophysiology, and Therapeutics
肌肉细胞生物学、病理生理学和治疗学
- 批准号:
9925057 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Muscle Cell Biology, Pathophysiology, and Therapeutics
肌肉细胞生物学、病理生理学和治疗学
- 批准号:
10614630 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Muscle Cell Biology, Pathophysiology, and Therapeutics
肌肉细胞生物学、病理生理学和治疗学
- 批准号:
10402837 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Restoration of muscle cell adhesion to treat cardiomyopathy in muscular dystrophy
恢复肌细胞粘附以治疗肌营养不良症中的心肌病
- 批准号:
9312863 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Muscle Cell Biology, Pathophysiology, and Therapeutics
肌肉细胞生物学、病理生理学和治疗学
- 批准号:
9267133 - 财政年份:2016
- 资助金额:
$ 31.78万 - 项目类别:
Novel Mechanisms to Enhance Utrophin Expression and Muscle Cell Function
增强 Utropin 表达和肌细胞功能的新机制
- 批准号:
7680821 - 财政年份:2009
- 资助金额:
$ 31.78万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.78万 - 项目类别:
Research Grant